Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences

GAITHERSBURG, Md., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences during the third quarter and early portion of the fourth quarter of 2018:

• Three Part Advisors – 2018 Midwest IDEAS Investor Conference Chicago, IL August 29-30, 2018 
• Wells Fargo Securities – 2018 Healthcare Conference Boston, MA September 5-6, 2018 
• Robert W. Baird & Co. – 2018 Global Healthcare Conference New York, NY September 5-6, 2018

• Morgan Stanley – 16th Annual Global Healthcare Conference New York, NY September 12-14, 2018

• Janney Montgomery Scott – Healthcare Conference 2018 New York, NY September 17-18, 2018

• Cantor Fitzgerald – Global Healthcare Conference 2018 New York, NY October 1-3, 2018

Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under “Investors” as the information becomes available.

For these conferences, the company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.

About Emergent BioSolutionsEmergent BioSolutions is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:Robert G. BurrowsVice President, Investor Relations240-631-3280[email protected]

Media Contact:Lynn KiefferVice President, Corporate Communications240-631-3391[email protected]

Source: Emergent BioSolutions

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Analog Devices (ADI) Reiterated at Overweight by Cantor Fitzgerald: Beat and Raise Expected
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low